be_ixf;ym_202512 d_26; ct_50
NASDAQ:PHAR charts & data provided by TradingView

Latest Insights on PHAR

The market is dying to COVID-19 fear, but Great Stuff is killing it… (Phrasing? Do we not do “phrasing” anymore?) While Wall Street Falls, Great Stuff Goes Alpha February 28, 2020 by Joseph Hargett 2020 Financial Crisis, Great Stuff Friday Four Play: The “Get a Leg up” Edition It’s no secret … I like being right. But to reference a line from The Matrix: “Not like this. Not like this.” So far this week, the Dow is off 3,200 points … and counting. Wall Street’s favorite barometer is down roughly 13% from its February […]
coronavirus fears and stock market increases This Play Is Set to Soar — With or Without the Coronavirus February 26, 2020 by Clint Lee 2020 Financial Crisis, Big Picture. Big Profits., Investment Opportunities, U.S. Economy [3-minute read] Demographic trends will deliver massive long-term profits.
Whatever your market plans, remember that Great Stuff is never gonna give you up, never gonna let you down … we’ll never run around or desert you! China’s Potential Doom; INO’s Biotech Boom February 14, 2020 by Joseph Hargett 2020 Financial Crisis, Great Stuff Friday Four Play: The “Never Gonna Give You Up” Edition Happy Valentine’s Day, dear readers! I don’t have chocolates, roses or even dinner reservations (I know, I’m a horrible date today). But I do have market data and stock gains for Great Stuff readers. Let’s start with the good news. U.S. retail sales rose for […]
For Seasoned Traders — 3 More Ways to Get Happy Rich This Year! February 8, 2020 by Kristen Barrett American Investor Today, Diversified Investments This week, we share four trading strategies that seasoned traders can follow to get “happy rich” in 2020. Strategy No. 1: Don’t lose money trying to guess earnings. Chad Shoop will show you how to profit from earnings after companies report. Strategy No. 2: Forget bonds and dividends for income. Chad Shoop has an income strategy that boasts a 97% win rate! Strategy No. 3: Natural resources such as oil and copper are volatile. But Matt Badiali and John Ross have a system to profit from the boom-bust cycle.
abbvie stock Profit From AbbVie’s Struggles Today February 4, 2020 by Chad Shoop American Investor Today, Stocks Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

Share This